CASP9 and Alzheimer disease: The levels of anti-apoptotic Bcl-2 and caspase inhibitors, BIRC3 and BIRC4 decreased and proapoptotic Bax increased in AD brain leading to activation of caspase-9, a marker for the intrinsic pathway of apoptosis.